Sen-Age
Biomarker1 paper2 findings
- Humans1
Upstream
1Cancer
upin humans1
1 study
Cancer
upin humans1
Cancer increases Sen-Age in humans (adj mean: -0.44 vs -0.83).
“Moreover, cancer survivors have higher Sen-Age score (adj mean: -0.44 ) than non-cancer controls (adj mean: -0.83).”
Humanscancer survivors compared to non-cancer controlsblood
SenMayo Based Aging Signature (Sen-Age) in cancer survivors: The Health and Retirement Study (HRS) · GSA 2025 abstract · 31 Dec 2025
Associations
1Mortality
upin humans1HR 1.47
1 study
Mortality
upin humans1HR 1.47
Sen-Age is associated with mortality in humans (HR: 1.47 [1.17–1.85] per 1 year).
“Sen-Age was associated with increased risk of mortality in cancer survivors (HR: 1.47 [1.17–1.85] per 1 year, p = 0.0008).”
Humansin cancer survivors, adjusted for age, sex, and raceblood4-yearn = 609
SenMayo Based Aging Signature (Sen-Age) in cancer survivors: The Health and Retirement Study (HRS) · GSA 2025 abstract · 31 Dec 2025